Cited by 966IL-33, ST2, and ILC PathwaysCytokine Signaling Pathways and InteractionsGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Open access

Carriere, Virginie, Roussel, Lucie, Ortega, Nathalie, Lacorre, Delphine-Armelle, Americh, Laure, Aguilar, Luc, Bouche, Gérard, Girard, Jean-Philippe·2007·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0606854104PMC PMC1765450

Open this paper in CoChat — free account

Abstract

Recent studies indicate that IL-1α functions intracellularly in pathways independent of its cell surface receptors by translocating to the nucleus and regulating transcription. Similarly, the chromatin-associated protein HMGB1 acts as both a nuclear factor and a secreted proinflammatory cytokine. Here, we show that IL-33, an IL-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, is an endothelium-derived, chromatin-associated nuclear factor with transcriptional repressor properties. We found that IL-33 is identical to NF-HEV, a nuclear factor preferentially expressed in high endothelial venules (HEV), that we previously characterized. Accordingly, in situ hybridization demonstrated that endothelial cells constitute a major source of IL-33 mRNA in chronically inflamed tissues from patients with rheumatoid arthritis and Crohn's disease. Immunostaining with three distinct antisera, directed against the N-terminal part and IL-1-like C-terminal domain, revealed that IL-33 is a heterochromatin-associated nuclear factor in HEV endothelial cells in vivo . Association of IL-33 with heterochromatin was also observed in human and mouse cells under living conditions. In addition, colocalization of IL-33 with mitotic chromatin was noted. Nuclear localization, heterochromatin-association, and targeting to mitotic chromosomes were all found to be mediated by an evolutionarily conserved homeodomain-like helix–turn–helix motif within the IL-33 N-terminal part. Finally, IL-33 was found to possess transcriptional repressor properties, associated with the homeodomain-like helix–turn–helix motif. Together, these data suggest that, similarly to IL1α and HMGB1, IL-33 is a dual function protein that may function as both a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0606854104

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
Schmitz, J., Owyang, A. M., Oldham, E. R., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,773
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin.
Brown, K., Guest, S. S., Smale, S., Hahm, K., Merkenschlager, M., & Fisher, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80472-9 · Cited by 824
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & TRAVERS, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 619
Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587

Show all 38 references

Research works printed but not linked: 1

CA Dinarello Eur Cytokine Netw 11, 483–486 (2000).

Sorted by citations

Items 401–500 of 965

Sex differences in the molecular signature of the developing mouse hippocampus
Bundy, J. L., Vied, C., & Nowakowski, R. S. (2017) · BMC Genomics · doi:10.1186/s12864-017-3608-7 · Cited by 54
Dichotomous function of IL-33 in health and disease: From biology to clinical implications
Braun, H., Afonina, I. S., Mueller, C., & Beyaert, R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.010 · Cited by 50
Basal epithelial stem cells cross an alarmin checkpoint for postviral lung disease
Wu, K., Kamimoto, K., Zhang, Y., Yang, K., Keeler, S. P., Gerovac, B. J., Agapov, E. V., Austin, S. R., Yantis, J., Gissy, K. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149336 · Cited by 50
Unconventional Pathways of Secretion Contribute to Inflammation
Daniels, M. J. D., & Brough, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010102 · Cited by 50
IL-33 released by alum is responsible for early cytokine production and has adjuvant properties
Rose, W., Okragly, A. J., Patel, C. N., & Benschop, R. J. (2015) · Scientific Reports · doi:10.1038/srep13146 · Cited by 51
Paracrine IL-33 Stimulation Enhances Lipopolysaccharide-Mediated Macrophage Activation
Ohno, T., Oboki, K., Morita, H., Kajiwara, N., Arae, K., Tanaka, S., Ikeda, M., Iikura, M., Akiyama, T., Inoue, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018404 · Cited by 49
IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma
Bianchetti, L., Marini, M. A., Isgrò, M., Bellini, A., Schmidt, M., & Mattoli, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.047 · Cited by 49
Sentinels at the wall: epithelial‐derived cytokines serve as triggers of upper airway type 2 inflammation
Patel, N. N., Kohanski, M. A., Maina, I. W., Workman, A. D., Herbert, D. R., & Cohen, N. A. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22206 · Cited by 48
IL-36 family cytokines in protective versus destructive inflammation
Han, Y., Huard, A., Mora, J., da Silva, P., Brüne, B., & Weigert, A. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109773 · Cited by 50
The IL-1 Family and Its Role in Atherosclerosis
González, L., Rivera, K., Andía, M. E., & Martı́nez-Rodrı́guez, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010017 · Cited by 51
Murine Mast Cells Secrete and Respond to Interleukin-33
Tung, H.-Y., Plunkett, B., Huang, S.-K., & Zhou, Y. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0066 · Cited by 48
Nuclear retention of IL‐1α by necrotic cells: A mechanism to dampen sterile inflammation
Luheshi, N., McColl, B. W., & Brough, D. (2009) · European Journal of Immunology · doi:10.1002/eji.200939712 · Cited by 48
Osteoblast Hypoxia-Inducible Factor-1α Pathway Activation Restrains Osteoclastogenesis via the Interleukin-33-MicroRNA-34a-Notch1 Pathway
Kang, H., Yang, K., Xiao, L., Guo, L., Guo, C.-J., Yan, Y., Jin, Q., Wang, F., Ryffel, B., Li, C., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01312 · Cited by 49
The Dynamics and Mechanisms of Interleukin‐1α and β Nuclear Import
Luheshi, N., Rothwell, N. J., & Brough, D. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00840.x · Cited by 48
Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival
Sawada, J., Hiraoka, N., Qi, R., Jiang, L., Fournier-Goss, A. E., Yoshida, M., Kawashima, H., & Komatsu, M. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0369 · Cited by 47
Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions
Guo, H., Bossila, E. A., Ma, X., Zhao, C., & Zhao, Y. X. (2022) · Cells · doi:10.3390/cells11203237 · Cited by 54
Natural Helper Cells
Koyasu, S., Moro, K., Tanabe, M., & Takeuchi, T. (2010) · Advances in immunology · doi:10.1016/b978-0-12-380995-7.00002-1 · Cited by 50
Interleukin 33 is induced by tumor necrosis factor alpha and interferon gamma in keratinocytes and contributes to allergic contact dermatitis.
Taniguchi, K., Yamamoto, S., Hitomi, E., Inada, Y., Suyama, Y., Sugioka, T., & Hamasaki, Y. (2013) · PubMed · Cited by 47
IL-33/ST2-mediated inflammation in macrophages is directly abrogated by IL-10 during rheumatoid arthritis
Chen, S., Chen, B., Wen, Z., Huang, Z. W., & Ye, L. (2017) · Oncotarget · doi:10.18632/oncotarget.16299 · Cited by 47
IL-33 in the basolateral amygdala integrates neuroinflammation into anxiogenic circuits via modulating BDNF expression
Zhuang, X., Zhan, B., Jia, Y., Li, C., Wu, N., Zhao, M., Chen, N., Guo, Y., Du, Y., Zhang, Y., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.02.019 · Cited by 48
Signaling and functions of interleukin-33 in immune regulation and diseases
Yi, X.-M., Lian, H., & Li, S. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100042 · Cited by 46
Type 2 Inflammation Drives an Airway Basal Stem Cell Program Through Insulin Receptor Substrate Signaling
Wang, X., Hallen, N. R., Lee, M., Samuchiwal, S. K., Ye, Q., Buchheit, K. M., Maxfield, A. Z., Roditi, R. E., Bergmark, R. W., Bhattacharyya, N., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.01.030 · Cited by 46
Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis
Lee, E.-J., So, M. W., Hong, S., Kim, Y., Yoo, B., & Lee, C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.10.005 · Cited by 46
Regulation of interleukin‐33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines
Nomura, K., Kojima, T., Fuchimoto, J., Obata, K., Keira, T., Himi, T., & Sawada, N. (2012) · The Laryngoscope · doi:10.1002/lary.23261 · Cited by 46
IL-33-ST2 Axis in Liver Disease: Progression and Challenge
Sun, Z., Chang, B., Gao, M., Zhang, J., & Zou, Z. (2017) · Mediators of Inflammation · doi:10.1155/2017/5314213 · Cited by 47
IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases
Du, L., Wang, Y., Hua, G., & Mi, W. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.11.028 · Cited by 46
Current perspectives on the interleukin‐1 family as targets for inflammatory disease
Hernandez-Santana, Y., Giannoudaki, E., León, G., Lucitt, M. B., & Walsh, P. T. (2019) · European Journal of Immunology · doi:10.1002/eji.201848056 · Cited by 47
Respiratory macrophages and dendritic cells mediate respiratory syncytial virus-induced IL-33 production in TLR3- or TLR7-dependent manner
Qi, F., Wang, D., Liu, J., Zeng, S., Xu, L., Hu, H., & Liu, B. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.10.022 · Cited by 46
Wounds that heal and wounds that don’t − The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
Millar, N. L., O’Donnell, C., McInnes, I. B., & Brint, E. K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.007 · Cited by 45
Sterile particle-induced inflammation is mediated by macrophages releasing IL-33 through a Bruton’s tyrosine kinase-dependent pathway
Mishra, P. K., Palma, M., Buechel, B., Moore, J., Davra, V., Chu, N., Millman, A., Hallab, N. J., Kanneganti, T., Birge, R. B., et al. (2019) · Nature Materials · doi:10.1038/s41563-018-0271-6 · Cited by 44
Fibroblast‐derived IL‐33 is dispensable for lymph node homeostasis but critical for CD8 T‐cell responses to acute and chronic viral infection
Aparicio‐Domingo, P., Cannelle, H., Buechler, M. B., Nguyen, S., Kallert, S. M., Favre, S., Alouche, N., Papazian, N., Ludewig, B., Cupedo, T., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.201948413 · Cited by 44
IL-1/IL-1R Signaling in Head and Neck Cancer
Niklander, S. E., Murdoch, C., & Hunter, K. D. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.722676 · Cited by 43
IL-33–Induced Hematopoietic Stem and Progenitor Cell Mobilization Depends upon CCR2
Kim, J., Kim, W., Le, H. T., Moon, U. J., Tran, V. G., Kim, H. J., Jung, S., Nguyen, Q.-T., Kim, B.-S., Jun, J., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400176 · Cited by 45
The multi‐faceted role of allergen exposure to the local airway mucosa
Golebski, K., Röschmann, K., Toppila-Salmi, S. K., Hammad, H., Lambrecht, B. N., Renkonen, R., Fokkens, W. J., & van Drunen, C. M. (2012) · Allergy · doi:10.1111/all.12080 · Cited by 46
Group 2 innate lymphoid cells: new players in human allergic diseases.
Doherty, T. A., & Broide, D. H. (2015) · PubMed · Cited by 44
The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?
Liu, X., Xiao, Y., Pan, Y., Li, H., Zheng, S. G., & Su, W. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.04.004 · Cited by 44
Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G
Mestrallet, G., Rouas‐Freiss, N., LeMaoult, J., Fortunel, N. O., & Martin, M. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772516 · Cited by 43
A role for interleukin-33 in TH2-polarized intestinal inflammation?
Seidelin, J. B., Rogler, G., & Nielsen, O. H. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.22 · Cited by 43
Osteoprotective Effects of IL-33/ST2 Link to Osteoclast Apoptosis
Lima, I. L. D. A., Macari, S., Madeira, M. F. M., Rodrigues, L. F. D., Colavite, P. M., Garlet, G. P., Soriani, F. M., Teixeira, M. M., Fukada, S. Y., & Silva, T. A. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.08.013 · Cited by 43
IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers?
Eissmann, M. F., Büchert, M., & Ernst, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01389 · Cited by 45
Interleukin‐33 alleviates diabetic cardiomyopathy through regulation of endoplasmic reticulum stress and autophagy via insulin‐like growth factor‐binding protein 3
Wu, M., Wang, S., Xie, Y., Chen, Z., Guo, Q., Yuan, W., Guan, C., Xu, C., Huang, Y., Wang, J., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30158 · Cited by 43
Role of the IL-33/ST2L axis in colorectal cancer progression
Akimoto, M., & Takenaga, K. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.014 · Cited by 42
Critical Roles of IL-33/ST2 Pathway in Neurological Disorders
Isnadi, M. F. A. R., Chin, V. K., Majid, R. A., Lee, T. Y., Abdullah, M. A., Bello, R. O., Ibraheem, Z. O., & Basir, R. (2018) · Mediators of Inflammation · doi:10.1155/2018/5346413 · Cited by 42
Interleukin-33 and ST2 Signaling in Tumor Microenvironment
Hong, J., Kim, S., & Lin, P. C. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0044 · Cited by 43
Caspase 1 deficiency reduces inflammation-induced brain transcription
Mastronardi, C. A., Whelan, F., Yildiz, O. A., Hannestad, J. O., Elashoff, D. A., McCann, S. M., Licinio, J., & Wong, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701366104 · Cited by 42
Microglia and Brain Macrophages as Drivers of Glioma Progression
Zheng, Y., & Graeber, M. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415612 · Cited by 40
SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in hepatocellular carcinoma cells to promote immune escape
Wang, Z., Pan, B., Qiu, J., Zhang, X., Ke, X., Shen, S., Wu, X., Yao, Y., & Tang, N. (2023) · Science Signaling · doi:10.1126/scisignal.abq3362 · Cited by 42
Serum amyloid A induces interleukin‐33 expression through an IRF7‐dependent pathway
Sun, L., Zhu, Z., Cheng, N., Yan, Q., & Ye, R. D. (2014) · European Journal of Immunology · doi:10.1002/eji.201344310 · Cited by 41
Research progress on interleukin-33 and its roles in the central nervous system
Han, P., Mi, W., & Wang, Y.-Q. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1025-5 · Cited by 41
IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response
Zhu, J., Wang, Y., Yang, F., Sang, L.-X., Zhai, J., Li, S., Li, Y., Wang, D., Lu, C., & Sun, X. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.08.032 · Cited by 41
IFN-γ Directly Controls IL-33 Protein Level through a STAT1- and LMP2-dependent Mechanism
Kopach, P., Lockatell, V., Pickering, E. M., Haskell, R. E., Anderson, R. D., Hasday, J. D., Todd, N. W., Luzina, I. G., & Atamas, S. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534396 · Cited by 41
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency
Martin, P., Talabot‐Ayer, D., Seemayer, C. A., Vigne, S., Lamacchia, C., Rodriguez, E., Finckh, A., Smith, D. E., Gabay, C., & Palmer, G. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4143 · Cited by 43
Interleukin-33: A Mediator of Inflammation Targeting Hematopoietic Stem and Progenitor Cells and Their Progenies
Le, H. T., Kim, W., Kim, J., Cho, H. R., & Kwon, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00104 · Cited by 42
Noncanonical intracrine action
Ré, R. N., & Cook, J. L. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.07.001 · Cited by 41
The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33
Ni, Y., Tao, L., Chen, C., Song, H., Li, Z., Gao, Y., Nie, J., Piccioni, M., Shi, G., & Li, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126063 · Cited by 41
Alarmins and central nervous system inflammation in HIV ‐associated neurological disorders
Gougeon, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12570 · Cited by 41
Helminth Infections Induce Tissue Tolerance Mitigating Immunopathology but Enhancing Microbial Pathogen Susceptibility
Yap, G. S., & Gause, W. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02135 · Cited by 43
NOD1 is required forHelicobacter pyloriinduction of IL-33 responses in gastric epithelial cells
Tran, L. S., Tran, D., Paoli, A. D., D’Costa, K., Creed, S. J., Ng, G. Z., Le, L., SUTTON, P. R. N., Silke, J., Nachbur, U., et al. (2018) · Cellular Microbiology · doi:10.1111/cmi.12826 · Cited by 42
Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis
Lin, C. Y., Pfluger, C. M., Henderson, R. D., & McCombe, P. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.05.001 · Cited by 41
IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study
Shen, J., Shang, Q., Wong, C. K., Li, E. K., Wang, S., Li, R., Lee, K.-L., Leung, Y.-Y., Ying, K.-Y., Yim, C.-W., et al. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.02.001 · Cited by 40
Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33
Kageyama, Y., Torikai, E., Tsujimura, K., & Kobayashi, M. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0480-1 · Cited by 40
Developmental expression of IL-33 in the mouse brain
Wicher, G., Husic, E., Nilsson, G. P., & Forsberg‐Nilsson, K. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.046 · Cited by 40
Similarities and differences in inflammatory mechanisms of asthma and COPD
Barnes, P. J. (2011) · Breathe · doi:10.1183/20734735.026410 · Cited by 42
The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape
Choi, M.-R., Sosman, J. A., & Zhang, B. (2021) · Cancers · doi:10.3390/cancers13133281 · Cited by 40
Allergy and Inflammation
Sokołowska, M., Głobińska, A., & Akdiş, C. A. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch38 · Cited by 40
Interleukin-33 mediates formalin-induced inflammatory pain in mice
Han, P., Zhao, J., Liu, S.-B., Yang, C.-J., Wang, Y., Wu, G. C., Xu, D., & Mi, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.019 · Cited by 40
Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population
Koyasu, S., & Moro, K. (2011) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283448808 · Cited by 39
Interleukin‐33 could play an important role in the pathogenesis of periodontitis
Köseoğlu, S., Hatipoğlu, M., Sağlam, M., Enhoş, Ş., & Esen, H. H. (2014) · Journal of Periodontal Research · doi:10.1111/jre.12235 · Cited by 39
Loss of Suppression of Tumorigenicity 2 (ST2) Gene Reverses Sepsis-induced Inhibition of Lung Host Defense in Mice
Hoogerwerf, J. J., Leendertse, M., Wieland, C. W., de Vos, A. F., de Boer, J. D., Florquin, S., & van der Poll, T. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0934oc · Cited by 41
Red Blood Cells Store and Release Interleukin-33
Wei, J., Zhao, J., Schrott, V. M., Zhang, Y., Gladwin, M. T., Bullock, G. C., & Zhao, Y. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000213 · Cited by 41
Pathophysiologic role of Interleukin-33/ST2 in Sjögren's syndrome
Soyfoo, M. S., & Nicaise, C. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102756 · Cited by 39
IL-33 in Rheumatic Diseases
Dong, Y., Zhong, J., & Dong, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.739489 · Cited by 43
IL-33: A central cytokine in helminth infections
McSorley, H. J., & Smyth, D. J. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101532 · Cited by 44
ST2 Protein in Heart Disease: From Discovery to Mechanisms and Prognostic Value
Weinberg, E. O. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.56 · Cited by 41
Biomarkers for cardiovascular disease: challenges and future directions
May, A., & Wang, T. J. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.04.003 · Cited by 39
Interleukin-33 in human gliomas: Expression and prognostic significance
Gramatzki, D., Frei, K., Cathomas, G., Moch, H., Weller, M., & Mertz, K. D. (2016) · Oncology Letters · doi:10.3892/ol.2016.4626 · Cited by 39
Intestinal IL-33 promotes microbiota-derived trimethylamine N-oxide synthesis and drives metabolic dysfunction–associated steatotic liver disease progression by exerting dual regulation on HIF-1α
Hai, S., Li, X., Xie, E., Wu, W., Gao, Q., Yu, B., Hu, J., Xu, F., Zheng, X., Zhang, B., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000985 · Cited by 38
IL-33 and kidney disease (Review)
Yang, F., ZHU, P., Duan, L., Yang, L., & Wang, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4516 · Cited by 37
Double-stranded RNA released from damaged articular chondrocytes promotes cartilage degeneration via Toll-like receptor 3-interleukin-33 pathway
Li, C.-W., Chen, K., Kang, H., Yan, Y.-F., Liu, K., Guo, C.-J., Qi, J., Yang, K., Wang, F., Guo, L., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.534 · Cited by 35
IL-33 contributes to disease severity in Psoriasis-like models of mouse
Duan, Y., Dong, Y.-H., Hu, H., Wang, Q., Guo, S. J., Fu, D., Song, X., Kalvakolanu, D. V., & Tian, Z. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.019 · Cited by 38
TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD
Canè, L., Poto, R., Palestra, F., Pirozzi, M., Parashuraman, S., Iacobucci, I., Ferrara, A. L., Rocca, A. L., Mercadante, E., Pucci, P., et al. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.02.020 · Cited by 39
Fecal Microbiota Transplantation Alleviates Airway Inflammation in Asthmatic Rats by Increasing the Level of Short-Chain Fatty Acids in the Intestine
Lai, Y.-T., Qiu, R.-R., Zhou, J., Ren, L., Qu, Y., & Zhang, G. (2025) · Inflammation · doi:10.1007/s10753-024-02233-w · Cited by 37
Nasal levels of soluble IL ‐33R ST 2 and IL ‐16 in allergic rhinitis: inverse correlation trends with disease severity
Baumann, R., Rabaszowski, M., Stenin, I., Tilgner, L., Gärtner-Akerboom, M., Scheckenbach, K., Wiltfang, J., Chaker, A. M., Schipper, J., & Wagenmann, M. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12148 · Cited by 37
Targeting ST2L Potentiates CpG-Mediated Therapeutic Effects in a Chronic Fungal Asthma Model
Ramaprakash, H., Shibata, T., Duffy, K. E., Ismailoglu, U. B., Bredernitz, R. M., Serezani, A. P. M., Coelho, A. L., Das, A., Fursov, N., Chupp, G. L., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.032 · Cited by 37
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33
Deng, K., Wang, H., Shan, T., Chen, Y., Zhou, H. Y., Zhao, Q., & Xia, J. (2016) · Scientific Reports · doi:10.1038/srep24505 · Cited by 38
Nuclear Alarmin Cytokines in Inflammation
Jiang, L., Shao, Y., Tian, Y., Ouyang, C., & Wang, X. (2020) · Journal of Immunology Research · doi:10.1155/2020/7206451 · Cited by 38
IL-33 is expressed in epithelia from patients with cystic fibrosis and potentiates neutrophil recruitment
Roussel, L., Farias, R., & Rousseau, S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.019 · Cited by 40
Self-citation
Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease
Kim, D.-J., Baek, S.-Y., Park, M.-K., Park, K.-S., Lee, J. H., Park, S., Kim, H., & Kwok, S. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.8.1145 · Cited by 37
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases
Thanikachalam, P. V., Ramamurthy, S., Mallapu, P., Varma, S. R., Jayaraj, K. N., Abourehab, M. A. S., & Kesharwani, P. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.06.003 · Cited by 38
The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer’s disease
Xiao, A.-W., He, J., Wang, Q., Luo, Y., Sun, Y., Zhou, Y., Yang, G., Lucassen, P. J., & Dai, J. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1736-7 · Cited by 36
Cancer stem cells and their niche in the progression of squamous cell carcinoma
Oshimori, N. (2020) · Cancer Science · doi:10.1111/cas.14639 · Cited by 38
The Paradigm of the Inflammatory Radicular Cyst: Biological Aspects to be Considered
Osorio, N. R. R., Caviedes‐Bucheli, J., Mosquera-Guevara, L., Adames-Martinez, J. S., Gomez-Pinto, D., Jimenez-Jimenez, K., Maz, H. H. A., & Bornacelly-Mendoza, S. (2022) · European Endodontic Journal · doi:10.14744/eej.2022.26918 · Cited by 35
Alarmin’ Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent Responses
Gajardo, T., Morales, R. A., Pérez, F., Terraza, C., Yáñez, L., Campos‐Mora, M., & Pino‐Lagos, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00232 · Cited by 35
Involvement of ERK and p38 MAPK pathways on Interleukin‐33‐induced RANKL expression in osteoblastic cells
Mine, Y., Makihira, S., Yamaguchi, Y., Tanaka, H., & Nikawa, H. (2014) · Cell Biology International · doi:10.1002/cbin.10249 · Cited by 36
Epithelial-derived nuclear IL-33 aggravates inflammation in the pathogenesis of reflux esophagitis
Shan, J., Oshima, T., Muto, T., Yasuda, K., Fukui, H., Watari, J., Nakanishi, K., & Miwa, H. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0988-1 · Cited by 36
The Evolutionary Role of the IL-33/ST2 System in Host Immune Defence
Sattler, S., Smits, H. H., Xu, D., & Huang, F. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0208-8 · Cited by 38
IL ‐33 polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in a birth cohort
Schröder, P. C., Casaca, V. I., Illi, S., Schieck, M., Michel, S., Böck, A., Roduit, C., Frei, R., Lluis, A., Genuneit, J., et al. (2016) · Pediatric Allergy and Immunology · doi:10.1111/pai.12597 · Cited by 35
Multifaceted roles of IL-38 in inflammation and cancer
Díaz-Barreiro, A., Huard, A., & Palmer, G. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155808 · Cited by 36
Novel Splice Variants of IL-33: Differential Expression in Normal and Transformed Cells
Tsuda, H., Komine, M., Karakawa, M., Etoh, T., Tominaga, S., & Ohtsuki, M. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.180 · Cited by 36
Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis
Ahmed, A., Hollan, I., Curran, S. A., Kitson, S. M., Riggio, M. P., Mikkelsen, K., Almdahl, S. M., Aukrust, P., McInnes, I. B., & Goodyear, C. S. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39574 · Cited by 35

Authors: Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P.
Affiliations: *Laboratoire de Biologie Vasculaire, Equipe Labellisée “La Ligue 2006,” Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5089, 205 Route de Narbonne, 31077 Toulouse, France; and
Centre National de la Recherche Scientifique (FR)
Endocube, Prologue Biotech, BP700, Rue Pierre et Marie Curie, 31319 Labège Cedex, France
Corresponding author: Girard, Jean-Philippe
ORCID: Roussel, Lucie
Aguilar, Luc
Girard, Jean-Philippe
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2007-01-02
Volume: 104
Issue: 1
Pages: 282-287
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0606854104
PMC: PMC1765450
OpenAlex: W2093396768
Cited by: 966
References: 38
Citations by year: 2026: 20 · 2025: 29 · 2024: 30 · 2023: 49 · 2022: 50 · 2021: 51 · 2020: 47 · 2019: 51 · 2018: 58 · 2017: 55 · 2016: 64 · 2015: 70 · 2014: 52 · 2013: 56 · 2012: 72
FWCI: 12.14
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Association pour la Recherche sur le Cancer
Drug Applied Research Center, Tabriz University of Medical Sciences
Topics: Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: IL-33, ST2 receptor, heterochromatin, nuclear factors, transcriptional repressor, endothelial cells, high endothelial venules, rheumatoid arthritis, Crohn's disease, chronic inflammation, HMGB1
MeSH terms: Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Animals, Arthritis, Rheumatoid, Crohn Disease, HeLa Cells, Heterochromatin, Humans, Interleukins, Membrane Proteins, Mitosis, Nuclear Proteins, Receptors, Cell Surface, Repressor Proteins, RNA, Messenger, 3T3 Cells, Conserved Sequence, Receptors, Interleukin, Nuclear Localization Signals, Amino Acid Motifs, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks